facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2022
vol. 109
 
Share:
Share:
abstract:
Case report

Narrow-band ultraviolet B as a treatment option in linear morphea

Andrew Yoshihiro Wirya
1
,
Nyoman Suryawati
1
,
Stephen Akihiro Wirya
2
,
Herman Saputra
1

  1. Universitas Udayana/RSUP Sanglah, Indonesia
  2. Boston University Medical Center, Boston, USA
Dermatol Rev/Przegl Dermatol 2022, 108, 236–243
Online publish date: 2022/10/21
View full text Get citation
 
PlumX metrics:
Introduction
Morphea, also known as localized scleroderma, is a condition characterized by fibrosis of the skin and underlying tissue. Linear morphea is an infrequent condition especially in adults. Treatment of morphea is challenging because of its recalcitrant nature. Therapeutic options include the use of phototherapy and systemic immunosuppressants with variable success. Phototherapy used in morphea also varies, with ultraviolet A1 (UVA1) being the most frequently used therapy; however, the availability of UVA1 is scarce and may increase the risk of skin cancer. Narrow-band ultraviolet B (NB-UVB) is much more readily available and presents a much lower risk of skin cancer.

Case report
Here we report a 27-year-old adult male with linear morphea on his lower extremity treated using NB-UVB. The patient underwent twenty sessions of NB-UVB and showed remarkable response to therapy.

Conclusions
This case report further highlights a treatment option for linear morphea using NB-UVB.

keywords:

morphea, phototherapy, photochemotherapy, NB-UVB, linear morphea



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.